- Home
- WLDS vs BCTX Comparison
WLDS vs BCTX Comparison
Compare WLDS & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLDS
- BCTX
- Stock Information
- Founded
- WLDS 2014
- BCTX 2014
- Country
- WLDS Israel
- BCTX Canada
- Employees
- WLDS N/A
- BCTX N/A
- Industry
- WLDS Computer Communications Equipment
- BCTX Biotechnology: Pharmaceutical Preparations
- Sector
- WLDS Telecommunications
- BCTX Health Care
- Exchange
- WLDS Nasdaq
- BCTX Nasdaq
- Market Cap
- WLDS 19.7M
- BCTX 21.8M
- IPO Year
- WLDS 2022
- BCTX N/A
- Fundamental
- Price
- WLDS $2.98
- BCTX $11.85
- Analyst Decision
- WLDS
- BCTX Strong Buy
- Analyst Count
- WLDS 0
- BCTX 1
- Target Price
- WLDS N/A
- BCTX $40.00
- AVG Volume (30 Days)
- WLDS 923.3K
- BCTX 78.8K
- Earning Date
- WLDS 09-09-2025
- BCTX 10-27-2025
- Dividend Yield
- WLDS N/A
- BCTX N/A
- EPS Growth
- WLDS N/A
- BCTX N/A
- EPS
- WLDS N/A
- BCTX N/A
- Revenue
- WLDS $422,000.00
- BCTX N/A
- Revenue This Year
- WLDS N/A
- BCTX N/A
- Revenue Next Year
- WLDS N/A
- BCTX $380.95
- P/E Ratio
- WLDS N/A
- BCTX N/A
- Revenue Growth
- WLDS N/A
- BCTX N/A
- 52 Week Low
- WLDS $1.00
- BCTX $6.00
- 52 Week High
- WLDS $16.96
- BCTX $190.50
- Technical
- Relative Strength Index (RSI)
- WLDS 39.65
- BCTX 62.04
- Support Level
- WLDS $3.28
- BCTX $10.76
- Resistance Level
- WLDS $4.07
- BCTX $12.76
- Average True Range (ATR)
- WLDS 0.46
- BCTX 0.77
- MACD
- WLDS -0.30
- BCTX -0.30
- Stochastic Oscillator
- WLDS 1.18
- BCTX 39.25
About WLDS Wearable Devices Ltd.
Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.